Hepatitis E virus infection activates signal regulator protein α to down-regulate type I interferon

Immunologic Research

Volumn 64, Issue 1, 2016, Pages 115-122

  Huang, Fen ^a,b   Yang, Chenchen ^a   Yu, Wenhai ^c   Bi, Yanhong ^a   Long, Feiyan ^a   Wang, Jue ^a   Li, Yunlong ^a   Jing, Shenrong ^a  

^a KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b KUNMING GENERAL HOSPITAL   (China)

^c INSTITUTE OF MEDICAL BIOLOGY   (China)

Author keywords

Hepatitis E virus; IFN ; IRF3; Signal regulator protein

Indexed keywords

BETA INTERFERON; INTERFERON; INTERFERON REGULATORY FACTOR 3; REGULATOR PROTEIN; SIGNAL REGULATOR PROTEIN ALPHA; UNCLASSIFIED DRUG; DIFFERENTIATION ANTIGEN; IMMUNOGLOBULIN RECEPTOR; IRF3 PROTEIN, HUMAN; SIRPA PROTEIN, HUMAN; SMALL INTERFERING RNA;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; HEPATITIS E; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; UPREGULATION; VIRUS CELL INTERACTION; VIRUS REPLICATION; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HEPATITIS E VIRUS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY; PHOSPHORYLATION; PHYSIOLOGY;

ANTIGENS, DIFFERENTIATION; GENE EXPRESSION REGULATION; HEK293 CELLS; HEPATITIS E; HEPATITIS E VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; MOLECULAR TARGETED THERAPY; PHOSPHORYLATION; RECEPTORS, IMMUNOLOGIC; RNA, SMALL INTERFERING; VIRUS REPLICATION;

EID: 84955755364     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-015-8729-y     Document Type: Article

References (28)

1. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012;55:988–97.
2. Kasorndorkbua C, Guenette DK, Huang FF, Thomas PJ, Meng XJ, Halbur PG. Routes of transmission of swine hepatitis E virus in pigs. J Clin Microbiol. 2004;42:5047–52.
3. Aggarwal R, Kamili S, Spelbring J, Krawczynski K. Experimental studies on subclinical hepatitis E virus infection in cynomolgus macaques. J Infect Dis. 2001;184:1380–5.
4. Aggarwal R, Jameel S. Hepatitis E. Hepatology. 2011;54:2218–26.
5. Takahashi M, Tanaka T, Azuma M, Kusano E, Aikawa T, Shibayama T, Yazaki Y, Mizuo H, Inoue J, Okamoto H. Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system. J Clin Microbiol. 2007;45:3671–9.
6. Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009;22:240–73.
7. Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, Du F, Ren J, Wu YT, Grishin NV, Chen ZJ. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science. 2015;347:aaa2630.
8. Devhare PB, Chatterjee SN, Arankalle VA, Lole KS. Analysis of antiviral response in human epithelial cells infected with hepatitis E virus. PLoS ONE. 2013;8:e63793.
9. Kharitonenkov A, Chen Z, Sures I, Wang H, Schilling J, Ullrich A. A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature. 1997;386:181–6.
10. de Vries HE, Hendriks JJ, Honing H, De Lavalette CR, van der Pol SM, Hooijberg E, Dijkstra CD, van den Berg TK. Signal-regulatory protein alpha-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium. J Immunol. 2002;168:5832–9.
11. Liu Y, Buhring HJ, Zen K, Burst SL, Schnell FJ, Williams IR, Parkos CA. Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration. J Biol Chem. 2002;277:10028–36.
12. Liu Y, O’Connor MB, Mandell KJ, Zen K, Ullrich A, Buhring HJ, Parkos CA. Peptide-mediated inhibition of neutrophil transmigration by blocking CD47 interactions with signal regulatory protein alpha. J Immunol. 2004;172:2578–85.
13. Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, Murphy-Ullrich JE, Bratton DL, Oldenborg PA, Michalak M, Henson PM. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell. 2005;123:321–34.
14. Oshima K, Machida K, Ichigotani Y, Nimura Y, Shirafuji N, Hamaguchi M, Matsuda S. SHPS-1: a budding molecule against cancer dissemination. Cancer Res. 2002;62:3929–33.
15. Dong LW, Kong XN, Yan HX, Yu LX, Chen L, Yang W, Liu Q, Huang DD, Wu MC, Wang HY. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction. Mol Immunol. 2008;45:3025–35.
16. Huang F, Hua XG, Yang SX, Yuan CL, Zhang W. Effective inhibition of hepatitis E virus replication in A549 cells and piglets by RNA interference (RNAi) targeting RNA-dependent RNA polymerase. Antiviral Res. 2009;83:274–81.
17. Triantafilou K, Triantafilou M. Coxsackievirus B4-induced cytokine production in pancreatic cells is mediated through toll-like receptor 4. J Virol. 2004;78:11313–20.
18. Huang R, Li D, Wei S, Li Q, Yuan X, Geng L, Li X, Liu M. Cell culture of sporadic hepatitis E virus in China. Clin Diagn Lab Immunol. 1999;6:729–33.
19. Tanaka T, Takahashi M, Kusano E, Okamoto H. Development and evaluation of an efficient cell-culture systemfor Hepatitis E virus. J Gen Virol. 2007;88:903–11.
20. Okamoto H. Cell culture system for hepatitis E virus. Uirusu. 2010;60:93–104.
21. Matsumoto M, Seya T. Recognition of dsRNA by toll-like receptor 3. Uirusu. 2001;51:209–14.
22. Seiffert M, Brossart P, Cant C, Cella M, Colonna M, Brugger W, Kanz L, Ullrich A, Buhring HJ. Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(−) hematopoietic cells. Blood. 2001;97:2741–9.
23. Latour S, Tanaka H, Demeure C, Mateo V, Rubio M, Brown EJ, Maliszewski C, Lindberg FP, Oldenborg A, Ullrich A, Delespesse G, Sarfati M. Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation. J Immunol. 2001;167:2547–54.
24. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem. 1998;67:227–64.
25. Dong C, Zafrullah M, Mixson-Hayden T, Dai X, Liang J, Meng J, Kamili S. Suppression of interferon-alpha signaling by hepatitis E virus. Hepatology. 2012;55:1324–32.
26. Chandra V, Kalia M, Hajela K, Jameel S. The ORF3 protein of hepatitis E virus delays degradation of activated growth factor receptors by interacting with CIN85 and blocking formation of the Cbl-CIN85 complex. J Virol. 2010;84:3857–67.
27. Zafrullah M, Ozdener MH, Panda SK, Jameel S. The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton. J Virol. 1997;71:9045–53.
28. Xu J, Wu F, Tian D, Wang J, Zheng Z, Xia N. Open reading frame 3 of genotype 1 hepatitis E virus inhibits nuclear factor-κappa B signaling induced by tumor necrosis factor-α in human A549 lung epithelial cells. PLoS ONE. 2014;9:e100787.